Seneca House Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$493K Buy
2,267
+63
+3% +$14K 0.2% 71
2025
Q4
$504K Buy
2,204
+27
+1% +$6.15K 0.19% 69
2025
Q3
$504K Buy
2,177
+84
+4% +$17.1K 0.2% 59
2025
Q2
$388K Buy
2,093
+56
+3% +$10.4K 0.17% 61
2025
Q1
$427K Buy
2,037
+6
+0.3% +$1.17K 0.18% 61
2024
Q4
$361K Sell
2,031
-56
-3% -$10.3K 0.14% 71
2024
Q3
$412K Buy
2,087
+47
+2% +$8.77K 0.17% 60
2024
Q2
$350K Buy
2,040
+34
+2% +$5.63K 0.15% 64
2024
Q1
$365K Sell
2,006
-5
-0.2% -$862 0.16% 67
2023
Q4
$312K Sell
2,011
-5
-0.2% -$729 0.14% 64
2023
Q3
$301K Buy
2,016
+27
+1% +$3.96K 0.16% 64
2023
Q2
$268K Hold
1,989
0.13% 70
2023
Q1
$317K Hold
1,989
0.16% 70
2022
Q4
$321K Hold
1,989
0.18% 70
2022
Q3
$267K Hold
1,989
0.2% 68
2022
Q2
$305K Sell
1,989
-1
-0.1% -$153 0.2% 72
2022
Q1
$323K Hold
1,990
0.17% 72
2021
Q4
$269K Buy
1,990
+21
+1% +$2.48K 0.14% 75
2021
Q3
$212K Hold
1,969
0.13% 84
2021
Q2
$222K Hold
1,969
0.14% 79
2021
Q1
$213K Buy
1,969
+24
+1% +$2.57K 0.15% 76
2020
Q4
$208K Buy
+1,945
New +$187K 0.15% 76
2019
Q2
Sell
-5,405
Closed -$436K 91
2019
Q1
$436K Sell
5,405
-1,287
-19% -$105K 0.38% 64
2018
Q4
$617K Sell
6,692
-171
-2% -$15K 0.58% 46
2018
Q3
$649K Buy
6,863
+497
+8% +$47.1K 0.51% 53
2018
Q2
$590K Buy
6,366
+2,550
+67% +$249K 0.48% 57
2018
Q1
$361K Buy
3,816
+828
+28% +$91K 0.3% 75
2017
Q4
$289K Buy
+2,988
New +$282K 0.25% 82

Other funds holding ABBV